Postmenopausal Osteoporosis
📧 Sign up to get email alerts when something new happens for Postmenopausal Osteoporosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-08-23FDA Approved: RALOXIFENE HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark Pharmaceuticals' supplemental application for raloxifene hydrochloride (generic). The drug is indicated for postmenopa…
-
FDA approval · 2019-07-09FDA Approved: RISEDRONATE SODIUM — Original Application (Sun Pharmaceutical Industires Inc.)
FDA approved Sun Pharmaceutical's risendronate sodium as an original application for a generic product, with indications for osteoporosis-re…
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With Osteoporosis [Phase 3]
Phase 3 trial update evaluating romosozumab in South Korean women with postmenopausal osteoporosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Romosozumab (AMG 785) [Phase 1]
Phase 1 multiple-dose study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of romosozumab in adults with postmenopa…
-
FDA approval · 2019-04-09FDA Approved: EVENITY — Original Application (Amgen, Inc)
FDA approved Amgen's romosozumab-aqqg (Evenity) for the treatment of osteoporosis in postmenopausal women at high risk for fracture. This en…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-03-25Clinical Trial Update: Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis [Phase 2]
Phase 2 clinical trial assessing efficacy, safety, and tolerability of Romosozumab in Japanese women with postmenopausal osteoporosis.
-
CLINICAL_TRIALS trial_result · 2019-03-11Clinical Trial Update: Zoledronic Acid to Maintain Bone Mass After Denosumab Discontinuation [Phase 4]
Phase 4 clinical trial evaluating zoledronic acid to maintain bone mass after stopping denosumab in postmenopausal osteoporosis.
-
CLINICAL_TRIALS research · 2019-02-21Clinical Trial Update: Sarcopenia And Balance In Postmenopausal Osteoporosis [NA]
An ongoing clinical trial led by Istanbul Medeniyet University studies sarcopenia and balance issues in postmenopausal osteoporosis, but the…
-
FDA approval · 2019-02-15FDA Approved: RISEDRONATE SODIUM — Original Application (Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd)
FDA approved the generic drug risedronate sodium under an Original Application, expanding access to this bisphosphonate for osteoporosis- an…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis
The clinical trial evaluating the effect of bisphosphonates on bone in postmenopausal osteoporosis has completed, reporting resolution of th…
-
CLINICAL_TRIALS research · 2019-02-06Clinical Trial Update: Validity of Korebalance Balance System [NA]
This clinical trial update evaluates the validity of the Korebalance Balance System for balance impairment in postmenopausal osteoporosis; c…
-
FDA approval · 2019-02-05FDA Approved: DOTTI — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal's original application for DOTTI, a generic estradiol product, expanding availability of estrogen replacement therap…
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: A Study of 2 Different Formulations of Blosozumab (LY2541546) in Post Menopausal Women [Phase 1]
A Phase 1 trial comparing two different formulations of Blosozumab (LY2541546) in postmenopausal women with osteoporosis was terminated, wit…
-
FDA approval · 2019-01-04FDA Approved: ESTRADIOL — Supplemental Application (PURACAP LABORATORIES, LLC)
The FDA granted approval for a supplemental application for Estradiol submitted by Puracap Laboratories, LLC, approving changes to an Estrad…
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis [Phase 3]
Phase 3 study evaluating the efficacy and safety of romosozumab for osteoporosis in postmenopausal women has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-08Clinical Trial Update: Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis [Phase 3]
Phase 3 trial update reporting efficacy and safety of romosozumab in postmenopausal osteoporosis; results completed and posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-08Clinical Trial Update: A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With Osteoporosis [Phase 3]
A Phase 3 randomized trial comparing two formulations of romosozumab in postmenopausal osteoporosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-08Clinical Trial Update: An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women [Phase 3]
Open-label Phase 3 trial comparing romosozumab and teriparatide in postmenopausal osteoporosis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-25Clinical Trial Update: G56W1 in Women With Postmenopausal Osteoporosis [Phase 1, Phase 2]
Phase 1/2 clinical trial update for G56W1 in postmenopausal osteoporosis.
-
FDA approval · 2018-08-27FDA Approved: ESTRADIOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Estradiol submitted by Mylan Pharmaceuticals Inc., granting regulatory approval for changes …
-
CLINICAL_TRIALS research · 2018-07-17Clinical Trial Update: Sarcopenia and Risk of Fall in Osteoporotic Postmenopausal Women [NA]
A clinical trial update examining sarcopenia and risk of falls in osteoporotic postmenopausal women; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: A Study of Blosozumab (LY2541546) in Postmenopausal Female Participants [Phase 1]
A Phase 1 study of Blosozumab (LY2541546) in postmenopausal women with osteoporosis has completed. Results were posted in July 2018.
-
FDA approval · 2018-06-20FDA Approved: TYMLOS — Supplemental Application (Radius Health, Inc.)
The FDA approved a supplemental application for TYMLOS (abaloparatide) by Radius Health, Inc. This action reflects an approved supplemental …
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis [Phase 4]
A Phase 4 study comparing patient dosing preferences for ibandronate and risedronate in Korean women with postmenopausal osteoporosis has co…
-
FDA approval · 2018-05-18FDA Approved: PROLIA — Supplemental Application (Amgen, Inc)
FDA approved a supplemental application for Prolia (denosumab) submitted by Amgen, related to the drug's labeling/indication via a supplemen…